Valutazione dei risultati dell'ablazione transcatetere della fibrillazione atriale

dai sintomi al monitoraggio continuo con loop recorder

Translated title of the contribution: Assessment of outcomes of atrial fibrillation transcatheter ablation: From symptoms to continuous monitoring with loop recorder

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pulmonary vein isolation by catheter ablation (CA) is an effective and indicated treatment for patients with drug refractory symptomatic atrial fibrillation (AF). It is noteworthy that patients with symptomatic AF show also a high incidence of asymptomatic episodes of arrhythmia. The main clinical studies on CA of AF have considered symptomatic recurrences of AF as the primary endpoint, thus potentially overestimating the success rate. Patient monitoring by means of daily transtelephonic ECG or repeated 7-day Holter has demonstrated an incidence of asymptomatic episodes of AF as high as 50% of all arrhythmic recurrences after CA. Moreover, the percentage of asymptomatic episodes significantly increases after CA. Changes in arrhythmia pattern and autonomic nervous system together with placebo effects and post-interventional antiarrhythmic therapy could account for the increase in asymptomatic episodes of AF observed after CA. A watchful monitoring of AF recurrences is of extreme importance not only to assess the real overall efficacy of CA but also to tailor therapeutic strategies for the individual patient. The decision to withdraw anticoagulation and antiarrhythmic therapies should be based on the demonstrated absence of both symptomatic and asymptomatic recurrences. The use of an implantable loop recorder with a dedicated software for AF and atrial tachycardia detection could be a valuable alternative to current monitoring strategies after CA of AF. Patient acceptability of such a minimally invasive strategy for AF monitoring has still to be proven.

Original languageItalian
JournalGiornale Italiano di Cardiologia
Volume9
Issue number10 SUPPL.1
Publication statusPublished - Oct 2008

Fingerprint

Atrial Fibrillation
Catheter Ablation
Outcome Assessment (Health Care)
Recurrence
Cardiac Arrhythmias
Placebo Effect
Pulmonary Veins
Autonomic Nervous System
Incidence
Physiologic Monitoring
Therapeutics
Tachycardia
Electrocardiography
Software
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{f687c4663028445c9baa246e6d2b618e,
title = "Valutazione dei risultati dell'ablazione transcatetere della fibrillazione atriale: dai sintomi al monitoraggio continuo con loop recorder",
abstract = "Pulmonary vein isolation by catheter ablation (CA) is an effective and indicated treatment for patients with drug refractory symptomatic atrial fibrillation (AF). It is noteworthy that patients with symptomatic AF show also a high incidence of asymptomatic episodes of arrhythmia. The main clinical studies on CA of AF have considered symptomatic recurrences of AF as the primary endpoint, thus potentially overestimating the success rate. Patient monitoring by means of daily transtelephonic ECG or repeated 7-day Holter has demonstrated an incidence of asymptomatic episodes of AF as high as 50{\%} of all arrhythmic recurrences after CA. Moreover, the percentage of asymptomatic episodes significantly increases after CA. Changes in arrhythmia pattern and autonomic nervous system together with placebo effects and post-interventional antiarrhythmic therapy could account for the increase in asymptomatic episodes of AF observed after CA. A watchful monitoring of AF recurrences is of extreme importance not only to assess the real overall efficacy of CA but also to tailor therapeutic strategies for the individual patient. The decision to withdraw anticoagulation and antiarrhythmic therapies should be based on the demonstrated absence of both symptomatic and asymptomatic recurrences. The use of an implantable loop recorder with a dedicated software for AF and atrial tachycardia detection could be a valuable alternative to current monitoring strategies after CA of AF. Patient acceptability of such a minimally invasive strategy for AF monitoring has still to be proven.",
keywords = "Atrial fibrillation, Catheter ablation, Continuous monitoring",
author = "Roberto Rordorf and Alessandro Vicentini and Maurizio Landolina",
year = "2008",
month = "10",
language = "Italian",
volume = "9",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "10 SUPPL.1",

}

TY - JOUR

T1 - Valutazione dei risultati dell'ablazione transcatetere della fibrillazione atriale

T2 - dai sintomi al monitoraggio continuo con loop recorder

AU - Rordorf, Roberto

AU - Vicentini, Alessandro

AU - Landolina, Maurizio

PY - 2008/10

Y1 - 2008/10

N2 - Pulmonary vein isolation by catheter ablation (CA) is an effective and indicated treatment for patients with drug refractory symptomatic atrial fibrillation (AF). It is noteworthy that patients with symptomatic AF show also a high incidence of asymptomatic episodes of arrhythmia. The main clinical studies on CA of AF have considered symptomatic recurrences of AF as the primary endpoint, thus potentially overestimating the success rate. Patient monitoring by means of daily transtelephonic ECG or repeated 7-day Holter has demonstrated an incidence of asymptomatic episodes of AF as high as 50% of all arrhythmic recurrences after CA. Moreover, the percentage of asymptomatic episodes significantly increases after CA. Changes in arrhythmia pattern and autonomic nervous system together with placebo effects and post-interventional antiarrhythmic therapy could account for the increase in asymptomatic episodes of AF observed after CA. A watchful monitoring of AF recurrences is of extreme importance not only to assess the real overall efficacy of CA but also to tailor therapeutic strategies for the individual patient. The decision to withdraw anticoagulation and antiarrhythmic therapies should be based on the demonstrated absence of both symptomatic and asymptomatic recurrences. The use of an implantable loop recorder with a dedicated software for AF and atrial tachycardia detection could be a valuable alternative to current monitoring strategies after CA of AF. Patient acceptability of such a minimally invasive strategy for AF monitoring has still to be proven.

AB - Pulmonary vein isolation by catheter ablation (CA) is an effective and indicated treatment for patients with drug refractory symptomatic atrial fibrillation (AF). It is noteworthy that patients with symptomatic AF show also a high incidence of asymptomatic episodes of arrhythmia. The main clinical studies on CA of AF have considered symptomatic recurrences of AF as the primary endpoint, thus potentially overestimating the success rate. Patient monitoring by means of daily transtelephonic ECG or repeated 7-day Holter has demonstrated an incidence of asymptomatic episodes of AF as high as 50% of all arrhythmic recurrences after CA. Moreover, the percentage of asymptomatic episodes significantly increases after CA. Changes in arrhythmia pattern and autonomic nervous system together with placebo effects and post-interventional antiarrhythmic therapy could account for the increase in asymptomatic episodes of AF observed after CA. A watchful monitoring of AF recurrences is of extreme importance not only to assess the real overall efficacy of CA but also to tailor therapeutic strategies for the individual patient. The decision to withdraw anticoagulation and antiarrhythmic therapies should be based on the demonstrated absence of both symptomatic and asymptomatic recurrences. The use of an implantable loop recorder with a dedicated software for AF and atrial tachycardia detection could be a valuable alternative to current monitoring strategies after CA of AF. Patient acceptability of such a minimally invasive strategy for AF monitoring has still to be proven.

KW - Atrial fibrillation

KW - Catheter ablation

KW - Continuous monitoring

UR - http://www.scopus.com/inward/record.url?scp=59849093166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849093166&partnerID=8YFLogxK

M3 - Articolo

VL - 9

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 10 SUPPL.1

ER -